“The apprehension with applying non IID shown ingredients is justified as it truly is difficult to evaluate if FDA would locate the ‘novel excipient’ Risk-free for use in a drug product as there isn't any outlined system for analysis and approval of excipients. The FDA steering on ‘Nonclinical Reports https://proleviate.com/